These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2544127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence for a saturable mechanism of disappearance of standard heparin in rabbits.
    Boneu B, Caranobe C, Gabaig AM, Dupouy D, Sie P, Buchanan MR, Hirsh J.
    Thromb Res; 1987 Jun 15; 46(6):835-44. PubMed ID: 3629550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A chronopharmacodynamic study on standard heparin, a low molecular weight heparin (nadroparin) and danaproid: establishing and comparing the daily variations of these drugs in rats.
    Abrial D, Blanc A, Réhailia M, Mismetti P, Bouchut C, Laporte-Simitsidis S, Decousus H, Buisson B.
    Haemostasis; 2000 Jun 15; 30(5):233-42. PubMed ID: 11251330
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic properties of long lasting butyryl heparin derivatives in the rabbit.
    Saivin S, Caranobe C, Petitou M, Lormeau JC, Houin G, Boneu B.
    Thromb Haemost; 1992 May 04; 67(5):550-5. PubMed ID: 1325682
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The haemorrhagic and antithrombotic effects of dermatan sulphate.
    Fernandez F, Van Ryn J, Ofosu FA, Hirsh J, Buchanan MR.
    Br J Haematol; 1986 Oct 04; 64(2):309-17. PubMed ID: 3778825
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic considerations on Orgaran (Org 10172) therapy.
    Danhof M, de Boer A, Magnani HN, Stiekema JC.
    Haemostasis; 1992 Oct 04; 22(2):73-84. PubMed ID: 1379967
    [Abstract] [Full Text] [Related]

  • 20. Neutralization of dermatan sulfate in vitro and in vivo by protamine sulfate and polybrene.
    Sié P, Cremers B, Dupouy D, Caranobe C, Dol F, Boneu B.
    Thromb Res; 1989 Apr 01; 54(1):63-74. PubMed ID: 2727957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.